Novartis says it will stick with drug development in India

Swiss drugs maker Novartis says its Indian subsidiary will continue to file patents for new drugs in India despite the rejection of its plea for patent protection for its anti-cancer treatment Gilvec.

Novartis' seven-year legal battle failed after India's Supreme Court ruled it was it was an amended version of an existing compound.

...
No Comment | euronews: watch the international news without commentary | http://www.euronews.net/nocomment/